The Complement C3a and C5a Signaling in Renal Diseases: A Bridge between Acute and Chronic Inflammation
Nephron · 2024
DOI: 10.1159/000538241 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nephron, 2024. Verfasst von Simona Buelli und 2 weiteren Autor:innen. Beteiligte Einrichtung: Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy. Hauptthemen laut MEDLINE: Complement C5a, Complement C3a, Signal Transduction, Inflammation. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 74 Literaturangaben.
Abstract (Originalsprache)
The complement system, a cornerstone of the innate immune defense, typically confers protection against pathogens. However, in various clinical scenarios the complement’s defensive actions can harm host cells, exacerbating immune and inflammatory responses. The central components C3 and C5 undergo proteolytic cleavage during complement activation, yielding small active fragments C3a and C5a anaphylatoxins. Traditionally, these fragments were associated with inflammation via the specific receptors C3a receptor (R), C5aR1 and C5aR2. Recent insights, however, spotlight the excessive C3a/C3aR and C5a/C5aR1 signaling as culprits in diverse disorders of inflammatory and autoimmune etiology. This is particularly true for several kidney diseases, where the potential involvement of anaphylatoxins in renal damage is supported by the enhanced renal expression of their receptors and the high levels of C3a and C5a in both plasma and urine. Furthermore, the production of complement proteins in the kidney, with different renal cells synthesizing C3 and C5, significantly contributes to local tissue injury. In the present review, we discuss the different aspects of C3a/C3aR and C5a/C5aR signaling in acute and chronic kidney diseases and explore the therapeutic potential of emerging targeted drugs for future clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy.
Zitieren
APA
Buelli, S., Imberti, B., & Morigi, M. (2024). The Complement C3a and C5a Signaling in Renal Diseases: A Bridge between Acute and Chronic Inflammation. Nephron. https://doi.org/10.1159/000538241
Vancouver
Buelli S, Imberti B, Morigi M. The Complement C3a and C5a Signaling in Renal Diseases: A Bridge between Acute and Chronic Inflammation. Nephron. 2024. doi:10.1159/000538241
BibTeX
@article{Buelli2024,
author = {Buelli, Simona and Imberti, Barbara and Morigi, Marina},
title = {The Complement C3a and C5a Signaling in Renal Diseases: A Bridge between Acute and Chronic Inflammation},
journal = {Nephron},
year = {2024},
doi = {10.1159/000538241}
}
EUVIMED